Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shadbolt, B.
Right arrow Articles by Craft, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shadbolt, B.
Right arrow Articles by Craft, P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
Journal of Clinical Oncology, Vol 20, Issue 10 (May), 2002: 2514-2519
© 2002 American Society for Clinical Oncology

Self-Rated Health as a Predictor of Survival Among Patients With Advanced Cancer

By Bruce Shadbolt, Jane Barresi, Paul Craft

From the Clinical Epidemiology and Health Outcomes Centre and the Medical Oncology Unit, Canberra Hospital, Canberra, Australia.

Address reprint requests to Paul Craft, MD, Medical Oncology Unit, Canberra Hospital, PO Box 11, Woden ACT, 2606, Australia; email: Paul.Craft{at}act.gov.au

PURPOSE: Evidence is emerging about the strong predictive relationship between self-rated health (SRH) and survival, although there is little evidence on palliative populations where an accurate prediction of survival is valuable. Thus, the relative importance of SRH in predicting the survival of ambulatory patients with advanced cancer was examined. SRH was compared to clinical assessments of performance status, as well as to quality-of-life measures.

PATIENTS AND METHODS: By use of a prospective cohort design, 181 patients (76% response rate) with advanced cancer were recruited into the study, resurveyed at 18 weeks, and observed to record deaths.

RESULTS: The average age of patients was 62 years (SD = 12). The median survival time was 10 months. SRH was the strongest predictor of survival from baseline. Also, a Cox regression comparing changes in SRH over time yielded hazard ratios suggesting the relative risk (RR) of dying was greater for fair ratings at 18 weeks (approximately 3 times) compared with consistent good or better ratings; the RR was even greater (4.2 and 6.2 times) for poor ratings, especially when ratings were poor at baseline and 18 weeks (31 times). Improvement in SRH over time yielded the lowest RR.

CONCLUSION: SRH is valid, reliable, and responsive to change as a predictor of survival of advanced cancer. These qualities suggest that SRH should be considered as an additional tool by oncologists to assess patients. Similarly, health managers could use SRH as an indicator of disease severity in palliative care case mix. Finally, SRH could provide a key to help us understand the human side of disease and its relationship with medicine.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Eur J Heart FailHome page
J. Farkas, S. Nabb, L. Zaletel-Kragelj, J. G.F. Cleland, and M. Lainscak
Self-rated health and mortality in patients with chronic heart failure
Eur J Heart Fail, May 1, 2009; 11(5): 518 - 524.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
E. A. Hahn, D. Cella, O. Chassany, D. L. Fairclough, G. Y. Wong, R. D. Hays, and Clinical Significance Consensus Meeting Group
Precision of Health-Related Quality-of-Life Data Compared With Other Clinical Measures
Mayo Clin. Proc., October 1, 2007; 82(10): 1244 - 1254.
[Abstract] [Full Text] [PDF]


Home page
Age AgeingHome page
S. Ayis, R. Gooberman-Hill, A. Bowling, and S. Ebrahim
Predicting catastrophic decline in mobility among older people
Age Ageing, July 1, 2006; 35(4): 382 - 387.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. M. Geraci, C. P. Escalante, J. L. Freeman, and J. S. Goodwin
Comorbid Disease and Cancer: The Need for More Relevant Conceptual Models in Health Services Research
J. Clin. Oncol., October 20, 2005; 23(30): 7399 - 7404.
[Full Text] [PDF]


Home page
JCOHome page
P. A. Glare, S. Eychmueller, and P. McMahon
Diagnostic Accuracy of the Palliative Prognostic Score in Hospitalized Patients With Advanced Cancer
J. Clin. Oncol., December 1, 2004; 22(23): 4823 - 4828.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
M. Lekander, S. Elofsson, I.-M. Neve, L.-O. Hansson, and A.-L. Unden
Self-rated Health Is Related to Levels of Circulating Cytokines
Psychosom Med, July 1, 2004; 66(4): 559 - 563.
[Abstract] [Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2002 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online